Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrochlorothiazide for Treatment of Urinary Tract Infection
IRCT20260723070321N1Phase 3Recruiting
- Sponsor
- Arak University of Medical Sciences
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of hydrochlorothiazide in urinary tract infection (UTI), sponsored by Arak University of Medical Sciences. Started Sep 2026; status: recruiting.
02
Drugs
hydrochlorothiazide
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on IRCT20260723070321N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260723070321N1.